IDT Management

From right to left: Shareholder Carsten Klocke, CEO Dr. Jürgen Betzing, Shareholder Stefan Klocke

IDT Biologika is a company of enduring strength, which we recognized with 100th-year anniversary celebrations in 2021. We are privileged to play a role in development and manufacture of the world’s leading vaccines, viral vectors, and therapeutics, which play an ongoing vital role in protecting people and improving quality of life for millions around the world. IDT Biologika has navigated 100 years and continues to bring value to customers as a result of our exceptional people.

Corporate Leadership Team

Dr. Jürgen Betzing
Chief Executive Officer
Dr. Jürgen Betzing brings with him more than 20 years of experience in business administration in the pharmaceutical industry. He received a degree in Pharmaceutical Technology from the University of Freiburg, with a qualification as Specialized Pharmacist, and holds a Business Administration degree from St. Gallen Business School.
Mario Schwager
Chief Operation Officer
Mario Schwager is Chief Operations Officer at IDT Biologika. For over 20 years, Mario has focused on sustainable optimization of the entire value chain by medium-sized and internationally operating industrial companies. He studied mechanical engineering and business administration with a focus on manufacturing engineering, organizational studies, and human resource management at the Technische Universität Braunschweig.
Prof. Dr. Ulrike Fiedler
Chief Commercial Officer
Dr. Ulrike Fiedler is Chief Commercial Officer at IDT Biologika. Ulrike has been with IDT Biologika since 2014, bringing her 28 years of biotech experience as well as entrepreneurial responsibility and science-based innovation to the role. Ulrike studied Biochemistry at the Martin-Luther-University Halle-Wittenberg, where she also received her doctor’s degree and has also been an Honorary Professor for Industrial Biotechnology since 2015.
Jürgen Kulbe
Chief Finance Officer
Jürgen Kulbe is Chief Financial Officer at IDT Biologika, responsible for Finance, IT, and Human Resources across all sites. He has held positions with global responsibility in various industry segments and has worked in the pharma industry for the last four years. Jürgen received his degree in Business Administration from Pforzheim University of Applied Science, with a focus on Accounting and Controlling, and received his Executive MBA from the University of St. Gallen.
Dr. Björn Riedel
Senior Vice President Quality
Björn Riedel leads the Quality Unit at IDT Biologika as the Chief Quality Officer. He has more than 19 years of experience in the manufacturing, testing, and quality management of vaccines and other drug products. By training, Björn is a graduated biologist, with a specialization in microbiology, genetics, biochemistry, and biotechnology, and is a registered European qualified person for human vaccines.
Dr. Simone Kardinahl
Vice President Development
Simone Kardinahl is Vice President of Development and has over 20 years of experience in the pharmaceutical industry, having held different positions in Research, Development, and Manufacturing of Biologics products. She studied Biochemistry at the University of Hannover and received her doctor’s degree in Biochemistry from the University of Lübeck.

North American Operations

Ashik Pavagadhi
VP Operations & Site Director US
Ashik Pavagadhi joined IDT Biologika in 2018 as US Site Director and Vice President of Operations. He brings with him more than 30 years of experience in biopharmaceutical start-ups and clinical and commercial manufacturing. He earned his B.Sc. from the University of Manitoba, Canada, and his M.B.A from Athabasca University, Canada.
Dr. Heidi Trusheim
Director Process Development
Heidi Trusheim is Director of Process Development at IDT Biologika. As a scientist, Heidi has expertise in developing, overseeing, and validating processes to manufacture and commercialize novel biological products. She has over 20 years of experience in research and development, with 15 years in the biopharmaceutical industry. Heidi received her doctor’s degree and M.Sc. from the University of Osnabrück.
Reginald Kidd III
Senior Director, Technical Operations
Reginald Kidd is the Senior Director of Technical Operations and joined IDT Biologika in 2015 when the Technical Operations Division of Aeras was acquired. Reginald has over 30 years of experience in biopharmaceutical manufacturing operations and received his B.Sc. in Biological Sciences from Old Dominion University.